BACKGROUND: To describe the relationship between glycaemic control, hyperglycaemic symptoms and quality of life (HRQOL) in type 2 diabetic patients. METHODS: In a shared-care diabetes project HRQOL was assessed. A total of 1664 patients with type 2 diabetes were identified in 32 primary healthcare practices. Of these patients, 1149 were included. HRQOL was measured using a generic questionnaire (Rand-36), completed by 1006 of the 1149 participants. RESULTS: The number of hyperglycaemic symptoms was higher in women (1.88) compared with men (1.64), without differences in mean haemoglobin A1c (HbA1c) (7.5%)-Univariate analyses showed negative relationships between all dimensions of the Rand-36 and hyperglycaemic symptoms (p<0.001), but between only one dimension and HbA1c (p=0.005). Multivariate analyses showed no association between any of the dimensions of the Rand-36 and HbA1c, but the relationship between hyperglycaemic symptoms persisted in all dimensions (p<0.001). Notwithstanding these results, the presence of hyperglycaemic symptoms was related to higher HbA1c. CONCLUSION: In type 2 diabetic patients, as assessed by a generic questionnaire, there is an evident relationship between hyperglycaemic symptoms and HRQOL and not between HbA1c and HRQOL. Subjective hyperglycaemic symptoms are, independent of HbA1c, important for HRQOL in type 2 diabetic patients, and should therefore not be neglected in the management of diabetes.
BACKGROUND: To describe the relationship between glycaemic control, hyperglycaemic symptoms and quality of life (HRQOL) in type 2 diabeticpatients. METHODS: In a shared-care diabetes project HRQOL was assessed. A total of 1664 patients with type 2 diabetes were identified in 32 primary healthcare practices. Of these patients, 1149 were included. HRQOL was measured using a generic questionnaire (Rand-36), completed by 1006 of the 1149 participants. RESULTS: The number of hyperglycaemic symptoms was higher in women (1.88) compared with men (1.64), without differences in mean haemoglobin A1c (HbA1c) (7.5%)-Univariate analyses showed negative relationships between all dimensions of the Rand-36 and hyperglycaemic symptoms (p<0.001), but between only one dimension and HbA1c (p=0.005). Multivariate analyses showed no association between any of the dimensions of the Rand-36 and HbA1c, but the relationship between hyperglycaemic symptoms persisted in all dimensions (p<0.001). Notwithstanding these results, the presence of hyperglycaemic symptoms was related to higher HbA1c. CONCLUSION: In type 2 diabeticpatients, as assessed by a generic questionnaire, there is an evident relationship between hyperglycaemic symptoms and HRQOL and not between HbA1c and HRQOL. Subjective hyperglycaemic symptoms are, independent of HbA1c, important for HRQOL in type 2 diabeticpatients, and should therefore not be neglected in the management of diabetes.
Authors: Anni B S Nielsen; Dorte Gannik; Volkert Siersma; Niels de Fine Olivarius Journal: Scand J Prim Health Care Date: 2011-06-27 Impact factor: 2.581
Authors: Jason C Levine; Edith Burns; Jeffrey Whittle; Raymond Fleming; Paul Knudson; Steve Flax; Howard Leventhal Journal: J Behav Med Date: 2016-07-01
Authors: Anni Brit Sternhagen Nielsen; Per Jensen; Dorte Gannik; Susanne Reventlow; Hanne Hollnagel; Niels de Fine Olivarius Journal: BMC Public Health Date: 2015-04-30 Impact factor: 3.295
Authors: Marta Dudzińska; Jerzy S Tarach; Thomas E Burroughs; Agnieszka Zwolak; Beata Matuszek; Agata Smoleń; Andrzej Nowakowski Journal: Arch Med Sci Date: 2014-10-23 Impact factor: 3.318
Authors: Yolanda V Martínez; Carlos A Prado-Aguilar; Ramón A Rascón-Pacheco; José J Valdivia-Martínez Journal: BMC Health Serv Res Date: 2008-07-30 Impact factor: 2.655